ATAI
Price:
$4.4
Market Cap:
$829.95M
Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.
Industry
Medical - Pharmaceuticals
IPO Date
2021-06-18
Stock Exchange
NASDAQ
Ticker
ATAI
According to Atai Beckley N.V’s latest financial reports and current stock price. The company's current Enterprise Value is 802.51M. This represents a change of 65.49% compared to the average of 484.94M of the last 4 quarters.
The mean historical Enterprise Value of Atai Beckley N.V over the last ten years is 1.24B. The current 802.51M Enterprise Value has changed 6.35% with respect to the historical average. Over the past ten years (40 quarters), ATAI's Enterprise Value was at its highest in in the March 2020 quarter at 3.06B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
1.24B
Median
551.58M
Minimum
198.06M
Maximum
3.00B
Discovering the peaks and valleys of Atai Beckley N.V Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.18%
Maximum Annual Enterprise Value = 3.00B
Minimum Annual Increase = -72.38%
Minimum Annual Enterprise Value = 198.06M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 220.21M | 11.18% |
| 2023 | 198.06M | -17.03% |
| 2022 | 238.72M | -72.38% |
| 2021 | 864.44M | -70.59% |
| 2020 | 2.94B | -2.17% |
The current Enterprise Value of Atai Beckley N.V (ATAI) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
219.00M
5-year avg
892.20M
10-year avg
1.24B
Atai Beckley N.V’s Enterprise Value is less than Nektar Therapeutics (1.22B), less than Inhibrx Biosciences, Inc. (1.13B), less than Enliven Therapeutics, Inc. (1.15B), less than Dianthus Therapeutics, Inc. (1.56B), less than ORIC Pharmaceuticals, Inc. (1.06B), less than Syndax Pharmaceuticals, Inc. (1.94B), less than Relay Therapeutics, Inc. (1.33B), less than Amylyx Pharmaceuticals, Inc. (985.24M), less than Immatics N.V. (919.37M), less than Sana Biotechnology, Inc. (1.39B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.22B | $1.17B | |
| 1.13B | $1.27B | |
| 1.15B | $1.27B | |
| 1.56B | $1.62B | |
| 1.06B | $1.11B | |
| 1.94B | $1.71B | |
| 1.33B | $1.39B | |
| 985.24M | $1.20B | |
| 919.37M | $1.44B | |
| 1.39B | $1.38B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atai Beckley N.V using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Atai Beckley N.V or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Atai Beckley N.V's Enterprise Value?
What is the highest Enterprise Value for Atai Beckley N.V (ATAI)?
What is the 3-year average Enterprise Value for Atai Beckley N.V (ATAI)?
What is the 5-year average Enterprise Value for Atai Beckley N.V (ATAI)?
How does the current Enterprise Value for Atai Beckley N.V (ATAI) compare to its historical average?